ClinicalTrials.Veeva

Menu

Eccentric Cycling Exercise During Pulmonary Rehabilitation Pulmonary Vascular Disease

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Enrolling

Conditions

Eccentric Cycling Exercise

Treatments

Procedure: Rehabilitation with eccentric cycling exercise
Procedure: normal rehabilitation

Study type

Interventional

Funder types

Other

Identifiers

NCT06480656
EccRehab

Details and patient eligibility

About

Eccentric cycling allows high intensities with low metabolic costs. Therefore the aim of this project is to investigate whether ECC improves exercise capacity and possibly hemodynamics during prolonged rehabilitation programs in patients with PVD

Full description

Eccentric cycling exercise (ECC) allows training at low metabolic costs and may therefore be valuable for patients with pulmonary vascular disease (PVD). For these patients, regular exercise training has an evidence level 1A recommendation in the current guidelines. Exercise training during longer and regular periods provides chronic adaptation, for which ECC was recently found to have a greater effectiveness than CON by increasing muscle strength, hypertrophy, six-minute walking distance and furthermore, by increasing maximum oxygen uptake (V'O2max) especially in patients with chronic obstructive pulmonary disease (COPD), chronic left heart failure or coronary heart disease.

Furthermore, the investigators conducted an RCT in which the investigators exposed patients with PVD to ECC and concluded that ECC is a feasible and well-tolerated exercise modality for PVD patients with severely lower O2 demand and load to the right ventricle.

Therefore the aim of this project is to investigate whether ECC improves exercise capacity and possibly hemodynamics during prolonged rehabilitation programs in patients with PVD.

Enrollment

22 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with PVD, either PAH or CTEPH according to recent guidelines
  • Stable medication for at least 1 month
  • Age 18 to 85 years
  • No resting hypoxemia (PaO2 >7.3kPa)

Exclusion criteria

  • Any co-morbidity that limits the patient to participate the full rehabilitation
  • Enrollments in other trials with active treatments

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

22 participants in 2 patient groups

Eccentric cycling exercise
Experimental group
Treatment:
Procedure: Rehabilitation with eccentric cycling exercise
Concentric cycling exercise
Active Comparator group
Treatment:
Procedure: normal rehabilitation

Trial contacts and locations

2

Loading...

Central trial contact

Silvia Ulrich, Prof; Julian Müller, Msc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems